Clinical Trial Update: PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating JS001 in combination with neoadjuvant chemotherapy for gastric cancer and gastroesophageal junction cancer is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• JS001 (PD-1 inhibitor)

Snippet

Sponsor: Wan He | Conditions: Stomach Neoplasms | Phase 2 | Status: RECRUITING